MMP8 and infection: In the current study, we got an unexpected result, revealed that the novel hemostatic, eCMC not only facilitates hemorrhage control, but it also decreased inflammatory cytokines, including MMP8, CINC1, and CINC3,18,19 allowing for a reduction the infection and inflammation risk, thus allowing for a wound environment conducive to wound healing.